The Rise of NK Cell Checkpoints as Promising Therapeutic Targets in Cancer Immunotherapy

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.02354
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Aptamers as a Promising Therapeutic Tool for Cancer Immunotherapy

2017English

Defective Cell Cycle Checkpoints as Targets for Anti-Cancer Therapies

Frontiers in Pharmacology
Pharmacology
2012English

The Blockade of Immune Checkpoints in Cancer Immunotherapy

Nature Reviews Cancer
Cancer ResearchOncology
2012English

Cell Surface Proteoglycans as Potential Targets for Immunotherapy in Women's Cancer

Journal of Gynecology and Womens Health
2017English

New Therapeutic Targets for Cancer: The Interplay Between Immune and Metabolic Checkpoints and Gut Microbiota

Clinical and Translational Medicine
MedicineMolecular Medicine
2019English

NK Cell-Based Glioblastoma Immunotherapy

Cancers
Cancer ResearchOncology
2018English

Rho GTPases as Therapeutic Targets in Cancer (Review)

International Journal of Oncology
Cancer ResearchOncology
2017English

Post-Translational Mechanisms Regulating NK Cell Activating Receptors and Their Ligands in Cancer: Potential Targets for Therapeutic Intervention

Frontiers in Immunology
AllergyImmunology
2019English

Oncogenes as Therapeutic Targets in Cancer: A Review

IOSR Journal of Dental and Medical Sciences
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy